Join
Live feed
·
PRReleasevia Quantisnow
Heartbeam Inc. logo

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

ByQuantisnow·Wall Street's wire, on your screen.
BEAT· Heartbeam Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BEAT (Heartbeam Inc.) and more on Quantisnow.